Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for TechTarget, Inc. > News item |
TechTarget greenshoe exercised, lifts 0% convertibles to $414 million
By Devika Patel
Knoxville, Tenn., Dec. 21 – Underwriters for TechTarget, Inc.'s offering of 0% five-year convertible senior notes exercised their over-allotment option in full for $54 million more of the convertibles, increasing the size of the issue to $414 million, the company reported in an 8-K filed Monday with the Securities and Exchange Commission.
As previously reported, the company sold the convertibles at par on Dec. 8 in a Rule 144A offering via bookrunners J.P. Morgan Securities LLC (lead left), Goldman Sachs & Co. LLC and Deutsche Bank Securities Inc.
The convertibles have an initial conversion premium of 37.5% and an initial conversion price of $131.50, which equals a conversion ratio of 7.6043.
The notes are non-callable until Dec. 20, 2024 and then subject to a 130% hurdle.
They are putable upon a fundamental change.
The notes will be settled in cash, shares or a combination of both at TechTarget’s option.
Concurrently with the offering, TechTarget repurchased or exchanged $149.9 million of its outstanding 0.125% convertible notes due 2025 for $147.1 million and 0.8 million shares in privately negotiated transactions.
Proceeds will be used to fund the cash portion of the repurchase or exchange of the 0.125% notes and for general corporate purposes, which may include repayment or further repurchases of outstanding debt, common stock repurchases, and future acquisitions.
TechTarget is a Newton, Mass.-based marketing and sales and service provider for tech companies.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.